Editorial Article
Steve Rees, of AstraZeneca, Discusses Cutting-edge Technologies for Drug Target Validation
Steve Rees, Vice-President of Screening Sciences and Sample Management, Talks to Kerry Parker
Steve Rees, Vice-President of Screening Sciences and Sample Management, Talks to Kerry Parker
PointMan used for non-invasive analysis for T790M mutations of EGFR
New technology wins prestigious award, presented at AACR 2015
Discover how the Director of the Stanford Cardiovascular Institute uses this technology
Hear what the Automation Engineer at DuPont Pioneer has to say
Don’t miss your chance to win an iPad Air
The SelectScience community tests the new website...
Hear what Exact Sciences' Service and Support Manager has to say
The Screening Facility Manager at Harvard Medical School gives us his views